[go: up one dir, main page]

WO2006067600A3 - Herbal formulations as cough lozenge - Google Patents

Herbal formulations as cough lozenge Download PDF

Info

Publication number
WO2006067600A3
WO2006067600A3 PCT/IB2005/003860 IB2005003860W WO2006067600A3 WO 2006067600 A3 WO2006067600 A3 WO 2006067600A3 IB 2005003860 W IB2005003860 W IB 2005003860W WO 2006067600 A3 WO2006067600 A3 WO 2006067600A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal formulations
formulations
polyherbal
cough lozenge
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/003860
Other languages
French (fr)
Other versions
WO2006067600A2 (en
Inventor
Chandra Kant Katiyar
Aravind Padiyar
Rahul Singh
Roopak Kumar
Anil Kanaujia
Navin Kumar Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006067600A2 publication Critical patent/WO2006067600A2/en
Publication of WO2006067600A3 publication Critical patent/WO2006067600A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to polyherbal pharmaceutical formulations in the form of lozenges which have been found to be effective in treating and managing coughs and sore throats. The invention also relates to processes for preparation, detection and quantitative analysis of individual phytochemicals used in the polyherbal formulations.
PCT/IB2005/003860 2004-12-23 2005-12-22 Herbal formulations as cough lozenge Ceased WO2006067600A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2550DE2004 2004-12-23
IN2550/DEL/2004 2004-12-23

Publications (2)

Publication Number Publication Date
WO2006067600A2 WO2006067600A2 (en) 2006-06-29
WO2006067600A3 true WO2006067600A3 (en) 2006-08-24

Family

ID=36182116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003860 Ceased WO2006067600A2 (en) 2004-12-23 2005-12-22 Herbal formulations as cough lozenge

Country Status (1)

Country Link
WO (1) WO2006067600A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017059088A1 (en) * 2015-09-30 2017-04-06 George Edward Hoag Topical analgesic pain relife formulations, manufacture and methods of use thereof
CN108760947A (en) * 2018-09-05 2018-11-06 翟纹静 The method of a variety of anesthetic in triple level four bars gas chromatography mass spectrometry detection aquatic products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US4980169A (en) * 1990-05-03 1990-12-25 Warner-Lambert Company Flavor enhancing and increasing efficacy of cough drops
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US4980169A (en) * 1990-05-03 1990-12-25 Warner-Lambert Company Flavor enhancing and increasing efficacy of cough drops
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"European Pharmacopoeia 4th Edition", 20 September 2001, EDQM COUNCIL OF EUROPE, STRASSBOURG, FRANCE, XP002382613 *
"European Pharmacopoeia 4th Edition", 20 September 2001, EDQM COUNCIL OF EUROPE, STRASSBOURG, FRANCE, XP002382614 *
ANONYMOUS: "Herbal/Ayurvedic", INTERNET ARTICLE, 31 October 2004 (2004-10-31), XP002382608, Retrieved from the Internet <URL:http://web.archive.org/web/20041031082625/http://www.acgil.com/archive/percos/other_products/branded_herbal001.htm> [retrieved on 20060524] *
ANONYMOUS: "Olbas Pastilles Throat Lozenges", INTERNET ARTICLE, 7 September 2003 (2003-09-07), XP002382855, Retrieved from the Internet <URL:http://web.archive.org/web/20030907164825/http://www.veganessentials.com/catalog/olbas-pastilles-throat-lozenges.htm> [retrieved on 20060524] *
SRIVASTAVA, S., VERMA, R.K., GUPTA, M.M., SINGH, S.C., AND KUMAR, S.: "HPLC determination of vasicine and vasicinone in Adhatoda vasica with photo diode array detection", JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, vol. 24, no. 2, 2001, pages 153 - 159, XP008064712 *

Also Published As

Publication number Publication date
WO2006067600A2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2006107745A3 (en) Composition for treatment of menopause
WO2006099579A3 (en) Compositions and methods for clonal amplification and analysis of polynucleotides
WO2010009342A3 (en) Inhibitors of bruton&#39;s tyrosine kinase for the treatment of solid tumors
WO2006130436A3 (en) Soybean event mon89788 and methods for detection thereof
NO20074753L (en) A pharmaceutical composition for treating depression and method of preparation thereof
WO2005086937A3 (en) Methods and compositions for inhibiting monoamine oxidase and catechol-l-methyltransferase
BRPI0718586A2 (en) COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, USES OF THIS AND METHOD OF TREATMENT OR PREVENTION OF DISEASES
WO2008013966A3 (en) Use of 8-quinolinol and its analogs to target cancer stem cells
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2006076003A3 (en) Vaccinia virus strains
WO2007059008A3 (en) N-substituted indenoisoquinolines and syntheses thereof
WO2007134350A8 (en) Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
WO2010041252A3 (en) Use of a cinnamon bark extract for treating amyloid-associated diseases
WO2008155390A3 (en) Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases.
WO2005089310A3 (en) Breath test for oral malodor
WO2006067600A3 (en) Herbal formulations as cough lozenge
WO2007028151A3 (en) Surgical devices and related methods thereof
WO2005049058A8 (en) Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases
EP1845928A4 (en) Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
ATE460168T1 (en) NON-RADIOACTIVE STRONTIUM AGENT FOR THE TREATMENT OF CANCER
SI1819320T1 (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
BR112012009369A2 (en) standardized plant extract, process for preparing sclerolobium plant extract, cosmetic composition, pharmaceutical composition and use of said extract
DK1906921T3 (en) Clear pharmaceutical aqueous microemulsion comprising propofol and method of preparation
WO2006134609A3 (en) Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05824913

Country of ref document: EP

Kind code of ref document: A2